These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30188580)

  • 1. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
    Ito K; Kawasaki T; Hirano K; Sekiguchi N
    Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
    Tagawa Y; Yuki N; Hirata K
    Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
    Gong D; Ji D; Xu B; Liu Z
    Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperviscosity syndrome, macroglobulinemia].
    Hatta Y; Sawada U
    Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
    Wang T; Xu B; Fan R; Liu Z; Gong D
    J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double filtration plasmapheresis: Review of current clinical applications.
    Hirano R; Namazuda K; Hirata N
    Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
    Lyu RK; Chen WH; Hsieh ST
    Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.
    Parmentier SP; Rosenkranz E; Schirutschke H; Opgenoorth M; Quick C; Hoelig K; Rosner A; Hohenstein B; Hugo C; Passauer J
    Atheroscler Suppl; 2017 Nov; 30():253-256. PubMed ID: 29096846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
    Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
    J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Settings for Double Filtration Plasmapheresis With Targeted Removal Rate of Preexisting Antibody in Antibody-Incompatible Kidney Transplant.
    Iwami D; Miura M; Chiba Y; Ota M; Matsumoto T; Hotta K; Sasaki H; Hirose T; Harada H; Shinohara N
    Transplant Proc; 2018 Dec; 50(10):3478-3482. PubMed ID: 30577224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
    Vatazin AV; Zulkarnaev AB
    Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.